Guanylhydrazones useful for treating diseases associated with T cell activation

Details for Australian Patent Application No. 2002300386 (hide)

Owner The Picower Institute for Medical Research

Inventors Schmidtmayerova, Helena; Bukrinsky, Michael; Cohen, Pamela; Tracey, Kevin

Agent Davies Collison Cave

Pub. Number AU-B-2002300386

Parent 54360

Filing date 2 August 2002

Wipo publication date 6 February 2003

Acceptance publication date 28 July 2005

International Classifications

A61K 031/15 - Oximes (CNO)

C07C 233/05 Carboxylic acid amides

A61K 031/155 - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-B-2002300386

28 July 2005 Assignment before Grant

  The Picower Institute for Medical Research The application has been assigned to Cytokine PharmaSciences, Inc.

28 July 2005 Application Accepted

  Published as AU-B-2002300386

24 November 2005 Standard Patent Sealed

1 November 2012 Assignment Registered

  Cytokine PharmaSciences, Inc. The patent has been assigned to Ferring B.V. Assignments Registered

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300387-Improved bridging member

2002300385-Immunogenic peptides from HPV E7 protein